NIH R01 · 2025
Engaging Patients in Prenatal Genetic Testing Decisions as a Pathway to Improve Obstetric Outcomes
PROJECT ABSTRACT The early and accurate diagnosis of congenital abnormalities using prenatal genetic screens and diagnostic tests (PS&D) is pivotal for patients to make healthcare decisions informed by medical facts and their values about pregnancy, children, family, and reproduction. A core component of high-quality, evidence-based, and equitable prenatal care, PS&D are also significant because congenital abnormalities are one of the leading causes of infant mortality in this country. The data obtained from testing is significant; it may lead some to un- dergo additional procedures to optimize neonatal outcomes or, if a serious condition is identified, to end the pregnancy. Given the…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.